JPL Wealth Management’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
Other funds holding NBIX
JPL Wealth Management's NBIX Position: Q3 2026 in Review
JPL Wealth Management held its Neurocrine Biosciences (NBIX) position steady in Q3 2026 at 56 shares worth $7.94K. The position accounts for ﹤0.01% of the portfolio, ranked #544.
JPL Wealth Management first reported a position in NBIX in Q1 2026 and has held it in 3 quarters since. The position peaked at $9.44K in Q2 2026. 773 funds tracked by Wall St. Rank hold NBIX as of Q3 2026.
- JPL Wealth Management held 56 shares of Neurocrine Biosciences worth $7.94K as of Q3 2026.
- JPL Wealth Management left its Neurocrine Biosciences share count unchanged in Q3 2026.
- Neurocrine Biosciences made up ﹤0.01% of JPL Wealth Management's portfolio in Q3 2026, its #544 holding.
- JPL Wealth Management first reported a position in Neurocrine Biosciences in Q1 2026 and has held it in 3 quarters since.
- JPL Wealth Management's Neurocrine Biosciences position peaked at $9.44K in Q2 2026.
- 773 funds tracked by Wall St. Rank held Neurocrine Biosciences as of Q3 2026.
Based on JPL Wealth Management's 13F filing for Q3 2026, filed 13 Nov 2026.